IP Verse

Pharmaceutical Formulations Comprising 4 {(1 R) 2 [(6 {2 [(2,6 Dichlorobenzyl)Oxy]Ethoxy}Hexyl)Amino] 1 Hydroxyethyl} 2 (Hydroxymethyl)Phenol - EP3578169

PATENT ANALYSIS

Patent Details

Grant Date
Jun 26, 2024
Company
GLAXO GROUP LIMITED
Oppositions

SANDOZ AG

More patents of Glaxo Group Limited

EP3578169

EP1907037

EP2005372

Want to monitor this patent?

Feel free to send us a message here and we will get back to you